Ceftriaxone Sodium
- Product NDC
- 43858-637
- 11-digit product format
- 438580637
- Labeler code
- 43858
- Product ID
- 43858-637_bbfeeeee-4664-4960-aab4-5b968d0ad5af
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Ceftriaxone Sodium
- Dosage form
- INJECTION, POWDER, FOR SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Sandoz GmbH
- Application
- ANDA065204
- Marketing category
- ANDA
- Marketing start
- 2005-05-03
- Marketing end
- 0000-00-00
- Substance
- CEFTRIAXONE SODIUM
- Active strength
- 2 g/1
- Pharmacologic classes
- Cephalosporin Antibacterial [EPC],Cephalosporins [CS]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A065204-001 | CEFTRIAXONE | CEFTRIAXONE SODIUM | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | 2005-05-03 | ||
| A065204-002 | CEFTRIAXONE | CEFTRIAXONE SODIUM | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | 2005-05-03 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A065204-001 | CEFTRIAXONE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | 2005-05-03 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A065204-002 | CEFTRIAXONE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | 2005-05-03 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A065204-001 | CEFTRIAXONE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2005-05-03 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A065204-002 | CEFTRIAXONE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2005-05-03 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A065204-001 | CEFTRIAXONE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2005-05-03 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A065204-002 | CEFTRIAXONE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2005-05-03 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A065204-001 | CEFTRIAXONE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2005-05-03 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A065204-002 | CEFTRIAXONE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2005-05-03 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A065204-001 | CEFTRIAXONE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2005-05-03 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A065204-002 | CEFTRIAXONE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2005-05-03 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A065204-001 | CEFTRIAXONE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2005-05-03 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A065204-002 | CEFTRIAXONE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2005-05-03 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A065204-001 | CEFTRIAXONE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2005-05-03 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A065204-002 | CEFTRIAXONE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2005-05-03 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A065204-001 | CEFTRIAXONE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2005-05-03 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A065204-002 | CEFTRIAXONE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2005-05-03 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A065204-001 | CEFTRIAXONE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2005-05-03 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A065204-002 | CEFTRIAXONE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2005-05-03 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A065204-001 | CEFTRIAXONE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2005-05-03 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A065204-002 | CEFTRIAXONE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2005-05-03 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A065204-001 | CEFTRIAXONE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2005-05-03 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A065204-002 | CEFTRIAXONE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2005-05-03 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A065204-001 | CEFTRIAXONE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2005-05-03 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A065204-002 | CEFTRIAXONE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2005-05-03 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A065204-001 | CEFTRIAXONE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2005-05-03 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A065204-002 | CEFTRIAXONE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2005-05-03 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A065204-001 | CEFTRIAXONE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2005-05-03 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A065204-002 | CEFTRIAXONE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2005-05-03 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A065204-001 | CEFTRIAXONE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2005-05-03 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | A065204-002 | CEFTRIAXONE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2005-05-03 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A065204-001 | CEFTRIAXONE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2005-05-03 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A065204-002 | CEFTRIAXONE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2005-05-03 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A065204-001 | CEFTRIAXONE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2005-05-03 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | A065204-002 | CEFTRIAXONE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2005-05-03 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A065204-001 | CEFTRIAXONE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2005-05-03 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | A065204-002 | CEFTRIAXONE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2005-05-03 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A065204-001 | CEFTRIAXONE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2005-05-03 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A065204-002 | CEFTRIAXONE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2005-05-03 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | A065204-001 | CEFTRIAXONE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2005-05-03 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | A065204-002 | CEFTRIAXONE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2005-05-03 | bb7c543d1eb4… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A065204-001 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A065204-002 | AP | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A065204-001 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A065204-002 | AP | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A065204-001 | AP | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A065204-002 | AP | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A065204-001 | AP | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A065204-002 | AP | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A065204-001 | AP | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A065204-002 | AP | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A065204-001 | AP | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A065204-002 | AP | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A065204-001 | AP | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A065204-002 | AP | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A065204-001 | AP | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A065204-002 | AP | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A065204-001 | AP | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A065204-002 | AP | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A065204-001 | AP | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A065204-002 | AP | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A065204-001 | AP | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A065204-002 | AP | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A065204-001 | AP | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A065204-002 | AP | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A065204-001 | AP | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A065204-002 | AP | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A065204-001 | AP | 1 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | A065204-002 | AP | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A065204-001 | AP | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A065204-002 | AP | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A065204-001 | AP | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | A065204-002 | AP | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A065204-001 | AP | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | A065204-002 | AP | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A065204-001 | AP | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A065204-002 | AP | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | A065204-001 | AP | 1 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | A065204-002 | AP | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A065204-001 | AP | 1 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | A065204-002 | AP | 1 | 782e0a99824c… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ceftriaxone Sodium | CEFTRIAXONE SODIUM | Hospira, Inc | 128bb292-d174-4769-b3e6-9f16617f31e3 | 2026-01-22 | Warnings, Adverse reactions | 065204 ANDA065204 |
| Ceftriaxone Sodium | CEFTRIAXONE SODIUM | Hospira, Inc | 9d1f630b-e759-4395-9d01-ddc90e4fea75 | 2022-03-09 | Warnings, Adverse reactions | 065204 ANDA065204 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 43858-637-95 | 43858063795 | 10 VIAL, SINGLE-USE in 1 CARTON (43858-637-95) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-USE | 2018-03-19 | 0000-00-00 | No | No | Current |